These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16247070)

  • 1. Analysis of LRRK2 functional domains in nondominant Parkinson disease.
    Skipper L; Shen H; Chua E; Bonnard C; Kolatkar P; Tan LC; Jamora RD; Puvan K; Puong KY; Zhao Y; Pavanni R; Wong MC; Yuen Y; Farrer M; Liu JJ; Tan EK
    Neurology; 2005 Oct; 65(8):1319-21. PubMed ID: 16247070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
    Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
    Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.
    Nichols WC; Elsaesser VE; Pankratz N; Pauciulo MW; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T;
    Neurology; 2007 Oct; 69(18):1737-44. PubMed ID: 17804834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations.
    Zabetian CP; Samii A; Mosley AD; Roberts JW; Leis BC; Yearout D; Raskind WH; Griffith A
    Neurology; 2005 Sep; 65(5):741-4. PubMed ID: 16157909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel variants in LRRK2 gene in patients with Parkinson's disease in Serbian population.
    Janković MZ; Kresojević ND; Dobričić VS; Marković VV; Petrović IN; Novaković IV; Kostić VS
    J Neurol Sci; 2015; 353(1-2):59-62. PubMed ID: 25899316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation.
    Johnson J; Paisán-Ruíz C; Lopez G; Crews C; Britton A; Malkani R; Evans EW; McInerney-Leo A; Jain S; Nussbaum RL; Foote KD; Mandel RJ; Crawley A; Reimsnider S; Fernandez HH; Okun MS; Gwinn-Hardy K; Singleton AB
    Neurodegener Dis; 2007; 4(5):386-91. PubMed ID: 17622782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
    Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
    Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRRK2: both a cause and a risk factor for Parkinson disease?
    Foroud T
    Neurology; 2005 Sep; 65(5):664-5. PubMed ID: 16157895
    [No Abstract]   [Full Text] [Related]  

  • 10. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.
    Zhang L; Quadri M; Guedes LC; Coelho M; Valadas A; Mestre T; Lobo PP; Rosa MM; Simons E; Oostra BA; Ferreira JJ; Bonifati V
    Parkinsonism Relat Disord; 2013 Oct; 19(10):897-900. PubMed ID: 23726462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.
    Lesage S; Janin S; Lohmann E; Leutenegger AL; Leclere L; Viallet F; Pollak P; Durif F; Thobois S; Layet V; Vidailhet M; Agid Y; Dürr A; Brice A; ; Bonnet AM; Borg M; Broussolle E; Damier P; Destée A; Martinez M; Penet C; Rasco O; Tison F; Tranchan C; Vérin M
    Arch Neurol; 2007 Mar; 64(3):425-30. PubMed ID: 17353388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of LRRK2 mutations and Parkinson's disease in Brazil.
    Pimentel MM; Moura KC; Abdalla CB; Pereira JS; de Rosso AL; Nicaretta DH; Campos M; de Almeida RM; dos Santos JM; Bastos IC; Mendes MF; Maultasch H; Costa FH; Werneck AL; Santos-Rebouças CB
    Neurosci Lett; 2008 Mar; 433(1):17-21. PubMed ID: 18201824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ancestry of LRRK2 Gly2019Ser parkinsonism.
    Benamer HT
    Lancet Neurol; 2008 Sep; 7(9):769-70; author reply 770-1. PubMed ID: 18702998
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of three novel LRRK2 mutations associated with Parkinson's disease in a Calabrian population.
    Anfossi M; Colao R; Gallo M; Bernardi L; Conidi ME; Frangipane F; Vasso F; Puccio G; Clodomiro A; Mirabelli M; Curcio SA; Torchia G; Smirne N; Di Lorenzo R; Maletta R; Bruni AC
    J Alzheimers Dis; 2014; 38(2):351-7. PubMed ID: 23963289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic Lrrk2 substitutions and Amyotrophic lateral sclerosis.
    Whittle AJ; Ross OA; Naini A; Gordon P; Mistumoto H; Dächsel JC; Stone JT; Wszolek ZK; Farrer MJ; Przedborski S
    J Neural Transm (Vienna); 2007 Mar; 114(3):327-9. PubMed ID: 16865326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Leucine-rich repeat kinase 2 (LRRK2) and Parkinson protein 2 (parkin, PARK2) genes mutations in Slovak Parkinson disease patients.
    Bognar C; Baldovic M; Benetin J; Kadasi L; Zatkova A
    Gen Physiol Biophys; 2013 Mar; 32(1):55-66. PubMed ID: 23531835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRRK2: a link between familial and sporadic Parkinson's disease?
    Lesage S; Dürr A; Brice A
    Pathol Biol (Paris); 2007 Mar; 55(2):107-10. PubMed ID: 16884863
    [No Abstract]   [Full Text] [Related]  

  • 18. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.
    Gaig C; Ezquerra M; Marti MJ; Muñoz E; Valldeoriola F; Tolosa E
    Arch Neurol; 2006 Mar; 63(3):377-82. PubMed ID: 16533964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRK2 mutations in Parkinson disease.
    Farrer M; Stone J; Mata IF; Lincoln S; Kachergus J; Hulihan M; Strain KJ; Maraganore DM
    Neurology; 2005 Sep; 65(5):738-40. PubMed ID: 16157908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease.
    Zabetian CP; Yamamoto M; Lopez AN; Ujike H; Mata IF; Izumi Y; Kaji R; Maruyama H; Morino H; Oda M; Hutter CM; Edwards KL; Schellenberg GD; Tsuang DW; Yearout D; Larson EB; Kawakami H
    Mov Disord; 2009 May; 24(7):1034-41. PubMed ID: 19343804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.